Staten Island, NY, United States of America

Inge Grundke-Ighal

This inventor holds 1 USPTO granted patent. Top assignee: Research Foundation for Mental Hygiene, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inge Grundke-Ighal. Retrieved from https://idiyas.com/inventor/inge-grundke-ighal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inge Grundke-Ighal: Innovator in Alzheimer's Disease Diagnosis

Introduction

Inge Grundke-Ighal is a notable inventor based in Staten Island, NY (US). She has made significant contributions to the field of Alzheimer's disease research. Her innovative approach focuses on differentiating subgroups of Alzheimer's disease, which can lead to more effective diagnosis and treatment.

Latest Patents

Inge holds a patent for a method that aids in the differentiation of Alzheimer's disease into distinct subgroups. The patent, titled "Method for differentiation of Alzheimer's Disease into subgroups," outlines a process that involves obtaining a sample of cerebrospinal fluid. The method determines the levels of ubiquitin, Aβ, and tau present in the sample. Based on these levels, the sample can be assigned to distinct subgroups, enhancing diagnostic accuracy.

Career Highlights

Inge is affiliated with the Research Foundation for Mental Hygiene, Inc., where she continues her work in mental health research. Her dedication to understanding Alzheimer's disease has positioned her as a key figure in this critical area of study.

Collaborations

Inge collaborates with esteemed colleagues, including Khalid Iqbal and Michael Flory. Their combined expertise contributes to advancing research in Alzheimer's disease and mental health.

Conclusion

Inge Grundke-Ighal's innovative work in diagnosing Alzheimer's disease subgroups represents a significant advancement in medical research. Her contributions are vital for improving patient outcomes and understanding this complex condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…